Multiple sclerosis: Current pathophysiological concepts

Laboratory Investigation

Volumn 81, Issue 3, 2001, Pages 263-281

  Wingerchuk, Dean M ^a   Lucchinetti, Claudia F ^b   Noseworthy, John H ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXONAL INJURY; CELLULAR IMMUNITY; DEMYELINATION; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REMYELINIZATION; REVIEW;

EID: 0035076486     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780235     Document Type: Review

References (172)

1. Functional diversity of helper T lymphocytes
2. The N-terminal domain of the myelin oligodendrocyte protein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat
3. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene
4. The B7-CD/28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system
5. Inhibition of experimental autoimmune encephalomyelitis by an antibody to intercellular adhesion molecule ICAM-1
6. The role of integrins in immune-mediated diseases of the nervous system
7. The role of B cells and autoantibodies in multiple sclerosis
8. A monoclonal autoantibody which promotes central nervous remyelination is highly polyreactive to multiple known and novel antigens
9. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
10. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
11. Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: An early event following inflammatory demyelination
12. The longstanding MS lesion: A quantitative MRI and electron microscopic study
13. Surface expression of alpha 4 integrin by CD4 cells is required for their entry into brain parenchyma
14. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?
15. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis
16. Clonally restricted production of the neurotrophins, brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2 polarized expression of their receptors
17. Chemokine and matrix metalloproteinase secretion by myelin proteolipid protein-specific CD8+ T cells: Potential roles in inflammation
18. Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
19. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
20. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS
21. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
22. Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system
23. Monocyte/macrophage differentiation in early multiple sclerosis lesions
24. The adhesion molecule and cytokine profile of MS lesions
25. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment
26. Molecular mechanisms of anti-inflammatory action of glucocorticoids
27. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis
28. Matrix metalloproteinases degrade myelin basic protein
29. Matrix metalloproteinases, tumour necrosis factor and multiple sclerosis: An overview
30. Histologie de la sclérose en plaque
31. The genetics of multiple sclerosis: Principles, background and updated results of the United Kingdom systematic genome screen
32. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin
33. Matrix metalloproteinase expression during autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and turnout necrosis factor-alpha inhibitor
34. Defective T cell Fas function in patients with multiple sclerosis
35. + T cell responses
36. 14C-labelled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis
37. Inducible nitric oxide synthase gene expression and enzymatic activity correlate with disease activity in murine experimental allergic encephalomyelitis
38. Evidence for the production of peroxynitrite in inflammatory CNS demyelination
39. The expression of tissue-type plasminogen activator, matrix metalloproteinases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution
40. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: Negative interference of activated glucocorticoid receptor with transcription factors
41. Immunocytochemical characterization of the expression of inducible and constitutive forms of nitric oxide synthase in demyelinating multiple sclerosis lesions
42. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis
43. Multiple sclerosis: Fas signaling in oligodendrocyte cell death
44. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
45. Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules
46. A population based study of multiple sclerosis in twins
47. A full genome search in multiple sclerosis
48. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group
49. E- and P- selectin are not involved in the recruitment of inflammatory cells across the blood brain barrier in experimental autoimmune encephalomyelitis
50. Immunoglobulin-containing cells in multiple sclerosis plaques
51. Association of the APOE epsilon4'allele with disease activity in multiple sclerosis
52. Axonal damage in acute multiple sclerosis lesions
53. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in multiple sclerosis
54. Peripheral blood γδ T cells lyse fresh human brain-derived oligodendrocytes
55. The association of the human herpesvirus-6 and MS
56. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of primary demyelinating lesion
57. Identification of autoantibodies associated with myelin damage in multiple sclerosis
58. Reversal of EAE with a hydroxymate inhibitor of matrix metalloproteinases
59. Chlamydia: A role for multiple sclerosis or more confusion?
60. Longitudinal study of soluble adhesion molecules in multiple sclerosis: Correlation with gadolinium-enhanced magnetic resonance imaging
61. Immunohistochemical studies of adult human glial cells
62. The significance of perivascular infiltrates in multiple sclerosis
63. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex
64. Probing degeneracy in T-cell recognition using peptide combinatorial libraries - Importance for T-cell survival and autoimmunity
65. The neuroprotective effect of inflammation: Implications for the therapy of multiple sclerosis
66. Apoptosis mediators FasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS
67. A metalloproteinase-disintegrin, MDC9/ meltrin-gamma/ADAM9 and PKC delta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor
68. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis
69. Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1
70. Activated human T cells, B cells and monocytes produce brain-derived neurotrophic factor (BDNF) in vitro and in brain lesions: A neuroprotective role for inflammation?
71. Effector pathways in immune mediated central nervous system demyelination
72. In vivo expression of inducible nitric oxide in experimentally induced neurologic disease
73. Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions
74. Balo concentric sclerosis: MR diagnosis
75. Genomewide scan of multiple sclerosis in Finnish families
76. Mylein basic protein specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease
77. Immunopathology of multiple sclerosis: Report on an international meeting held at the Institute of Neurology of the University of Vienna
78. Ecologic studies of multiple sclerosis
79. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study
80. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis
81. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors
82. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
83. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study
84. Axonal changes in chronic demyleinated cervical spinal cord plaques
85. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis
86. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis
87. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions: A study of 113 cases
88. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
89. Humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
90. Chemokines - Chemotactic cytokines that mediate inflammation
91. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions
92. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis
93. Proinflammatory cytokines regulate antigen-independent T cell activation by two separate calcium signaling pathways in multiple sclerosis patients
94. Immunopathogenesis of multiple sclerosis: The role of T cells
95. A very high level of crossreactivity is an essential feature of the T-cell receptor
96. Serum soluble adhesion molecules in multiple sclerosis: Raised sVCAM-1, slCAM-1, and sE-selectin in primary progressive disease
97. Malignant monophasic multiple sclerosis or "Marburg's disease"
98. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions
99. Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients
100. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
101. The British Isles survey of multiple sclerosis in twins
102. Perforin-dependent neurologic injury in a viral model of multiple sclerosis
103. Immunoglobulin G Fc-receptor (Fc γ R) IIA and IIIB polymorphisms related to disability in MS
104. Cytokines and the pathogenesis of multiple sclerosis
105. Progress in determining the causes and treatment of multiple sclerosis
106. Multiple sclerosis
107. A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis
108. IV immunoglobulin does not reverse established weakness in MS. A double-blind, placebo-controlled trial
109. Cytokines induce the development of functionally heterogeneous T helper cell subsets
110. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis
111. Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase
112. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis
113. Repertoire requirements of CD4+ T cells that prevent spontaneous autoimmune encephalomyelitis
114. Exacerbations of multiple sclerosis in patients treated with gamma interferon
115. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement
116. Gluatamate excitotoxicity in a model of multiple sclerosis
117. Glutamate excitotoxicity as a mechanism of axonal damage in multiple sclerosis
118. Interferon-gamma modulates human oligodendroglial susceptibility to Fas-mediated apoptosis
119. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis
120. Demyelinating diseases
121. The Dale E. McFarlin Memorial Lecture: The immunology of the multiple sclerosis lesion
122. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation
123. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats
124. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases
125. Nitric oxide donors reversibly block axonal conduction: Demyelinated axons are especially susceptible
126. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study
127. Immunoglobulins promote remyelination in the central nervous system
128. Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease
129. Ultrastructure of multiple sclerosis
130. Immunoglobulins reactive with myelin basic protein promote CNS remyelination
131. The Th1/Th2 paradigm
132. T cell adhesion to endothelial cells and extracellular matrix is modulated upon transendothelial migration
133. A population-based study of multiple sclerosis in twins: Update
134. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
135. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
136. Association of interleukin-1 beta and interleukin-1 receptor antagonist genes with disease severity in MS
137. Problems of experimental trials of therapy in MS: Report of the panel on evaluation of experimental trials in MS
138. Oligodendrocyte susceptibility to injury by T-cell perforin
139. Colocalization of lymphocytes bearing gamma delta T cell receptor and heat shock hsp65 oligodendrocytes in multiple sclerosis
140. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
141. A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain
142. Nerve conduction block by nitric oxide that is mediated by the axonal environment
143. Demyelination: The role of reactive oxygen and nitrogen species
144. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
145. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
146. Evidence for involvement of ICAM-1 and VCAM-1 in the lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse
147. More mayhem from molecular mimics
148. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination
149. Autoimmunity to myelin oligodendrocyte glycoprotein (MOG) in rats mimics the spectrum of multiple sclerosis pathology
150. Nerve growth factor is an autocrine survival factor for memory B lymphocytes
151. Axonal transection in the lesions of multiple sclerosis
152. Autoreactive CD8+ T cell responses to human myelin protein-derived peptides
153. Migratory behavior of lymphocytes isolated from multiple sclerosis patients: Effects of interferon beta-1b therapy
154. Antigen-independent activation of naïve and memory resting T cells by a cytokine combination
155. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation
156. Promotion of remyelination by polyclonal immunoglobulin and IVIg in Theiler's virus induced demyelination and in MS
157. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis
158. Modifications of peptide ligands enhancing T cell responsiveness suggest a broad spectrum of stimulatory ligands for autoreactive T cells
159. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability
160. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease
161. Major histocompatibility complex class II alleles and the course and outcome of MS: A population-based study
162. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanasess
163. The clinical course of neuromyelitis optica (Devic's syndrome)
164. Structural and functional aspects of the interaction of inflammatory cells with the blood-brain barrier in experimental brain inflammation
165. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells
166. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin
167. Interferon beta in the treatment of multiple sclerosis: Mechanisms of action
168. Matrix metalloproteinases and diseases of the CNS
169. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis
170. Aberrant T cell migration towards RANTES and MIP-1 α in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5
171. Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis